New: Introducing the Finviz Crypto Map

Learn More
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#141 / 200 Total
HCTI - Healthcare Triangle Inc - Stock Price Chart
TickerHCTI [NASD]
CompanyHealthcare Triangle Inc
CountryUSA
IndustryHealth Information Services
Market Cap7.89MEPS (ttm)-0.92
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.70EPS next 5Y-
P/B0.27EPS Q/Q58.67%
Dividend-Sales Q/Q-9.86%
Insider Own0.32%Inst Own0.24%
Insider Trans0.00%Inst Trans35.66%
Short Float0.83%Earnings-
Analyst Recom1.00Target Price15.00
Avg Volume406.63M52W Range- - 1.90
Healthcare Triangle, Inc. operates as a healthcare information technology company, which engages in advancing various solutions for the cloud services, data science, and professional and managed services sectors for the healthcare and life sciences industry. It operates through the following segments: Software Services, Managed Services and Support, and Platform Services. The Software Services segment focuses on the sale of software services that are generated from providing strategic advisory, implementation, and development services. The Managed Services and Support segment includes post implementation support and cloud hosting. The Platform services segment offers solutions under CloudEz, DataEz, and Readabl.AI. The company was founded by Suresh Venkatachari and Keith T. Ryan on October 29, 2019 and is headquartered in Pleasanton, CA.
VOR - Vor Biopharma Inc - Stock Price Chart
TickerVOR [NASD]
CompanyVor Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap276.16MEPS (ttm)-1.51
P/E-EPS this Y56.45%
Forward P/E-EPS next Y36.23%
PEG-EPS past 5Y-38.02%
P/S-EPS next 5Y18.66%
P/B4.18EPS Q/Q42.54%
Dividend-Sales Q/Q-
Insider Own48.06%Inst Own42.14%
Insider Trans-0.01%Inst Trans-4.39%
Short Float27.82%EarningsMay 08
Analyst Recom2.60Target Price1.18
Avg Volume18.06M52W Range0.13 - 3.29
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Robert AngOfficerJul 16 '25Proposed Sale2.10197,937415,391Jul 16 04:07 PM
Robert AngOfficerJul 15 '25Proposed Sale2.43214,135520,586Jul 15 05:29 PM
Robert AngOfficerJul 10 '25Proposed Sale2.33596,8851,388,091Jul 10 04:22 PM
ROBERT ANGOfficerJul 02 '25Proposed Sale1.7944,93680,435Jul 02 04:40 PM
ROBERT ANGOfficerJul 01 '25Proposed Sale1.7240,46869,613Jul 01 04:58 PM
NEO - Neogenomics Inc - Stock Price Chart
TickerNEO [NASD, RUT]
CompanyNeogenomics Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap803.06MEPS (ttm)-0.61
P/E-EPS this Y38.70%
Forward P/E20.88EPS next Y95.83%
PEG-EPS past 5Y-
P/S1.19EPS next 5Y66.44%
P/B0.90EPS Q/Q5.17%
Dividend-Sales Q/Q7.55%
Insider Own1.38%Inst Own96.37%
Insider Trans4.42%Inst Trans2.76%
Short Float3.58%EarningsJul 29/b
Analyst Recom1.93Target Price10.50
Avg Volume2.22M52W Range6.08 - 19.11
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williams FeliciaDirectorJun 01 '25Option Exercise0.007,16007,160Jun 03 04:08 PM
KANOVSKY STEPHEN MDirectorJun 01 '25Option Exercise0.0012,254052,344Jun 03 04:08 PM
Kelly Michael AaronDirectorJun 01 '25Option Exercise0.0012,254044,009Jun 03 04:08 PM
TETRAULT LYNN A.DirectorJun 01 '25Option Exercise0.0012,254073,652Jun 03 04:07 PM
Floegel ElizabethDirectorJun 01 '25Option Exercise0.0012,254023,590Jun 03 04:07 PM
IART - Integra Lifesciences Holdings Corp - Stock Price Chart
TickerIART [NASD, RUT]
CompanyIntegra Lifesciences Holdings Corp
CountryUSA
IndustryMedical Devices
Market Cap864.93MEPS (ttm)-0.38
P/E-EPS this Y-12.52%
Forward P/E4.53EPS next Y9.70%
PEG-EPS past 5Y-
P/S0.53EPS next 5Y2.70%
P/B0.57EPS Q/Q-683.89%
Dividend-Sales Q/Q3.74%
Insider Own15.54%Inst Own97.66%
Insider Trans0.00%Inst Trans9.60%
Short Float10.15%EarningsJul 31/b
Analyst Recom3.08Target Price16.12
Avg Volume1.32M52W Range11.06 - 32.56
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 11 '25Option Exercise0.002,35604,391Mar 13 04:24 PM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 10 '25Option Exercise0.001,18002,359Mar 11 04:16 PM
Schwartz EricEVP, Chief Legal Officer & SecDec 03 '24Sale24.594,070100,10259,511Dec 04 04:32 PM
Schwartz EricOfficerDec 03 '24Proposed Sale24.594,070100,102Dec 03 05:30 PM
McBreen Michael J.EVP & President, CSSDec 02 '24Sale24.161,70041,06456,182Dec 03 04:19 PM
INNV - InnovAge Holding Corp - Stock Price Chart
TickerINNV [NASD, RUT]
CompanyInnovAge Holding Corp
CountryUSA
IndustryMedical Care Facilities
Market Cap530.60MEPS (ttm)-0.23
P/E-EPS this Y-8.62%
Forward P/E97.04EPS next Y123.30%
PEG-EPS past 5Y-
P/S0.64EPS next 5Y-
P/B2.23EPS Q/Q-94.46%
Dividend-Sales Q/Q12.99%
Insider Own84.88%Inst Own12.05%
Insider Trans0.07%Inst Trans1.34%
Short Float1.60%EarningsMay 06/a
Analyst Recom3.50Target Price5.00
Avg Volume40.04K52W Range2.60 - 6.69
InnovAge Holding Corp. engages in managing the care of high-cost, frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). The company program is dedicated to enabling older adults to age independently in their own homes for as long as safely possible. It offers interdisciplinary care teams and community-based care delivery models. The company was founded in 2007 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ZORETIC RICHARD CDirectorMay 28 '25Buy4.0620,00081,20045,779May 30 05:08 PM
ZORETIC RICHARD CDirectorMay 29 '25Buy4.0414,26557,63160,044May 30 05:08 PM
ZORETIC RICHARD CDirectorMay 30 '25Buy4.088,45034,47668,494May 30 05:08 PM
ZORETIC RICHARD CDirectorMay 21 '25Buy4.131,1474,73723,881May 23 04:31 PM
ZORETIC RICHARD CDirectorMay 23 '25Buy3.931,1984,70825,779May 23 04:31 PM
ONDS - Ondas Holdings Inc - Stock Price Chart
TickerONDS [NASD]
CompanyOndas Holdings Inc
CountryUSA
IndustryCommunication Equipment
Market Cap389.72MEPS (ttm)-0.58
P/E-EPS this Y49.51%
Forward P/E-EPS next Y48.70%
PEG-EPS past 5Y11.28%
P/S36.02EPS next 5Y53.84%
P/B10.92EPS Q/Q15.11%
Dividend-Sales Q/Q579.70%
Insider Own11.84%Inst Own10.11%
Insider Trans-0.16%Inst Trans14.50%
Short Float3.31%EarningsMay 15/b
Analyst Recom1.40Target Price2.50
Avg Volume15.64M52W Range0.54 - 3.40
Jul-09-25 08:30AM Ondas Holdings to Host Virtual Investor Day Today, July 9, 2025, at 1:00 PM EDT Focused on Ondas Autonomous Systems and Reports Preliminary Q2 2025 Financial Results (ACCESSWIRE)
Jul-07-25 08:30AM Ondas Holdings Enters Strategic Partnership with KLEAR to Expand Access to Non-Dilutive Working Capital Across the Emerging Defense Technology Ecosystem (ACCESSWIRE) -5.41%
Jun-29-25 12:02PM Two Workers for SEC-Edgar Filing Agent Face Insider Charges (Bloomberg)
Jun-25-25 08:30AM Ondas' American Robotics Partners with Detroit Manufacturing Systems to Scale U.S. Drone Manufacturing to Meet Increasing Demand (ACCESSWIRE)
Jun-24-25 08:30AM Ondas and Mistral Sign Strategic Partnership to Accelerate U.S. Defense and Homeland Security Sales for Autonomous Drone Platforms (ACCESSWIRE) +11.19%
Jun-20-25 08:30AM Ondas to Host Virtual Investor Day Highlighting Updated Business Strategy and Growth Initiatives for its Ondas Autonomous Systems Business Unit on July 9, 2025 (ACCESSWIRE)
Jun-16-25 08:30AM Ondas' American Robotics Secures Purchase Order from a Major Urban Public Safety Organization in the U.S. for the Kestrel System, an Advanced Drone Detection and Counter-UAS Solution (ACCESSWIRE) -7.14%
Jun-11-25 04:15PM Ondas Holdings Regains Full Nasdaq Compliance (ACCESSWIRE) +15.54%
12:05PM Ondas Holdings Inc. Announces Closing of $46 Million Public Offering Including Full Exercise of Overallotment Option (ACCESSWIRE)
08:24AM Zacks Industry Outlook Highlights A10 Networks and Ondas (Zacks)
Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COHEN RICHARD MDirectorJun 17 '25Option Exercise0.0021,0350190,422Jun 18 09:52 PM
COHEN RICHARD MDirectorJun 17 '25Sale1.697,56712,788182,855Jun 18 09:52 PM
SOOD JASPREET KDirectorJun 17 '25Option Exercise0.0021,0350170,330Jun 18 09:49 PM
SOOD JASPREET KDirectorJun 17 '25Sale1.698,67314,657161,657Jun 18 09:49 PM
Sood Jaspreet KDirectorJun 17 '25Proposed Sale1.698,67314,657Jun 18 09:47 PM
NEGG - Newegg Commerce Inc - Stock Price Chart
TickerNEGG [NASD]
CompanyNewegg Commerce Inc
CountryUSA
IndustryInternet Retail
Market Cap573.16MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y43.78%
P/S-EPS next 5Y-
P/B-EPS Q/Q-364.23%
Dividend-Sales Q/Q-27.42%
Insider Own98.89%Inst Own0.44%
Insider Trans3.66%Inst Trans16.78%
Short Float271.84%EarningsApr 28/b
Analyst Recom1.00Target Price60.00
Avg Volume738.67K52W Range3.32 - 56.00
Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Galkin Vladimir10% OwnerJul 17 '25Buy29.41111,1113,267,9982,777,777Jul 18 01:14 PM
Galkin Vladimir10% OwnerJul 16 '25Buy28.17111,1113,129,77426,622,221Jul 18 01:14 PM
Galkin Vladimir10% OwnerJul 15 '25Buy29.56111,1113,284,7002,555,555Jul 16 12:51 PM
Galkin Vladimir10% OwnerJul 14 '25Buy41.14222,2229,141,7452,444,444Jul 15 12:15 PM
Galkin Vladimir10% OwnerJul 09 '25Buy21.7757,9201,260,9182,222,222Jul 14 07:14 PM
RYET - Ruanyun Edai Technology Inc - Stock Price Chart
TickerRYET [NASD]
CompanyRuanyun Edai Technology Inc
CountryChina
IndustryEducation & Training Services
Market Cap80.33MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own62.28%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float2.49%Earnings-
Analyst Recom-Target Price-
Avg Volume1.21M52W Range1.50 - 21.00
Ruanyun Edai Technology, Inc. provides artificial intelligence to educational institutions. It offers new teaching, learning, and assessment methods in the artificial intelligence. The firm involves in reforming traditional Chinese education and learning model by facilitating schools, teachers and students. The company was founded by Yan Fu and Cong Zhao on March 11, 2021 and is headquartered in Nanchang, China.
BHVN - Biohaven Ltd - Stock Price Chart
TickerBHVN [NYSE, RUT]
CompanyBiohaven Ltd
CountryUSA
IndustryBiotechnology
Market Cap1.43BEPS (ttm)-9.37
P/E-EPS this Y16.89%
Forward P/E-EPS next Y17.59%
PEG-EPS past 5Y-49.78%
P/S-EPS next 5Y18.05%
P/B5.53EPS Q/Q1.15%
Dividend-Sales Q/Q-
Insider Own12.68%Inst Own88.83%
Insider Trans0.25%Inst Trans-1.67%
Short Float13.73%EarningsMay 12/a
Analyst Recom1.25Target Price54.21
Avg Volume2.18M52W Range13.04 - 55.70
Jul-15-25 08:59AM Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform (Insider Monkey) -6.55%
Jun-10-25 02:00PM Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development (GlobeNewswire)
May-29-25 07:01AM Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor (PR Newswire)
12:16AM Biohaven Ltd. (BHVN)'s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy (Insider Monkey)
May-28-25 03:00PM Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN) (PR Newswire)
07:30AM Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors (PR Newswire)
May-15-25 06:03PM Why Biohaven Stock Dove by Nearly 20% on Thursday (Motley Fool) -19.53%
02:06PM Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug (Investor's Business Daily)
01:22PM Why Is Biohaven Stock Falling On Thursday? (Benzinga)
May-14-25 06:43PM FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia (PR Newswire)
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHILDS JOHN WDirectorMar 04 '25Buy30.4732,700996,2382,320,571Mar 05 07:01 AM
Car BruceChief Scientific OfficerJan 05 '25Option Exercise0.004,75007,133Jan 07 08:51 PM
Gentile KimberlySVP, Clinical OperationsJan 05 '25Option Exercise0.003,750099,719Jan 07 08:50 PM
Clark George C.VP, Chief Accounting OfficerJan 05 '25Option Exercise0.002,500066,168Jan 07 08:50 PM
Buten MatthewChief Financial OfficerJan 05 '25Option Exercise0.004,2500196,013Jan 07 08:49 PM
BQ - Boqii Holding Limited - Stock Price Chart
TickerBQ [AMEX]
CompanyBoqii Holding Limited
CountryChina
IndustrySpecialty Retail
Market Cap8.03MEPS (ttm)-0.62
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y68.13%
P/S0.10EPS next 5Y-
P/B1.53EPS Q/Q99.82%
Dividend-Sales Q/Q-8.13%
Insider Own2.83%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.29%Earnings-
Analyst Recom1.00Target Price587.66
Avg Volume64.71K52W Range2.39 - 1184.00
Boqii Holding Ltd. operates as a holding company with interest in operating online pet stores. It provides services through its subsidiaries. The company was founded by Liang Hao, Tang Yingzhi, and Chen Di in December 2007 and is headquartered in Shanghai, China.
11011121314151617181920